Table 2. Results of meta-analysis for IGFBP3 A-202C/Gly32Ala polymorphism and colorectal cancer.
Genotype Comparisons | OR (95% C.I.) | P | Ph | I2 |
A-202C | ||||
AC vs. AA | 0.99(0.88–1.11) | 0.89 | 0.77 | 0% |
CC vs. AA | 1.06(0.92–1.22) | 0.40 | 0.62 | 0% |
CC+AC vs. AA | 0.98(0.88–1.09) | 0.71 | 0.89 | 0% |
CC Vs. AC+AA | 0.94(0.84–1.05) | 0.28 | 0.63 | 0% |
Gly32Ala | ||||
GC vs. GG | 1.10(0.92–1.31) | 0.32 | 0.13 | 47% |
CC vs. GG | 0.93(0.76–1.14) | 0.49 | 0.13 | 46% |
CC+GC vs. GG | 1.07(0.81–1.42) | 0.62 | 0.05 | 61% |
CC Vs. GC+GG | 0.90(0.77–1.05) | 0.17 | 0.31 | 16% |
Ph P value of Q test for heterogeneity.